Investor Relations

Listed On The Shanghai Stock Exchange In June 2001, With A Maximum Market Value Of 47.5 Billion

Ad hoc announcement pursuant to Art. 53 LR-JCARE Announcement on Resolutions of 2024 Fourth Extraordinary General Meeting

Time:2024-09-23

Ad hoc announcement pursuant to Art. 53 LR-JCARE Announcement On the Additional Ad Hoc Proposal for the Fourth Extraordinary General Meeting in 2024

Time:2024-09-10

Ad hoc announcement pursuant to Art. 53 LR-JCARE Notice of 2024 Fourth Extraordinary General Meeting

Time:2024-09-02

Ad hoc announcement pursuant to Art. 53 LR-JCARE Announcement on the Plan for the Repurchase of Shares of the Company by Means of Centralized Bidding Transactions

Time:2024-09-02

Ad hoc announcement pursuant to Art. 53 LR-JCARE Announcement on Completion of the Re-Election of the Board of Directors and The Supervisory Committee of the Company

Time:2024-08-27

Ad hoc announcement pursuant to Art. 53 LR-JCARE Announcement on Resolutions of 2024 Third Extraordinary General Meeting

Time:2024-08-27

Ad hoc announcement pursuant to Art. 53 LR-JCARE Indicative Announcement on Acceptance of Application for Registration and Marketing Authorization of TG-1000 Capsule

Time:2024-08-12

Ad hoc announcement pursuant to Art. 53 LR-JCARE Announcement on the Re-Election of the Board of Directors and the Supervisory Committee

Time:2024-08-06

Ad hoc announcement pursuant to Art. 53 LR-JCARE Notice of 2024 Third Extraordinary General Meeting

Time:2024-08-06

Ad hoc announcement pursuant to Art. 53 LR-Announcement on the Implementation of 2023 Profit Distribution of JCARE

Time:2024-07-11

< 1...345...12 >